July 14, 2010
The food resources are limited and more and more under pressure due to the massive growth in population. The fuel resources are limited and under pressure by a continuously expanding industry. The health is under pressure too because of less money available for medical systems even in the developed economies. Biotechnology had, has and will have a key role in finding solutions for these issues. On the other hand, biotechnology has a good potential for investors as any new discovery could turn over night in a huge financial success.
Venture Capital Industry focus on biotechnology can be explained by the ability of this field of science to turn millions of Euro invested into billions. There is no reason not to believe that similar good opportunities will not come in the future. Biotechnology has its roots and it is more developed in the United States, but Europe is increasing the pace in supporting this industry especially by creating a proper legal environment. Clusters of biotechnology developed in the last decade even in Central Europe in countries like Poland or Czech Republic but the most developed ones are in the UK, Germany, France or Scandinavian countries and a good reason for this is that Venture Capital Industry in more developed in these markets.
Biotechnology is dependent on investment companies. It takes several years and huge amounts money to develop a new drug or a better seed. It takes even more money for tests and marketing. There are not so many companies that can have the patience and funds to support this. Still, biotechnology can offer a very attractive return on investment that no so many other industries are capable to offer. This is why these two industries are very closely connected. There are many biotechnology projects supported by venture capital firms and there are many VC funds that invested in biotechnology and you can find no less than 791 here and many other will probably follow them in the near future.